Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Nightingale Health Plc: Unaudited financial information in accordance with IFRS for the comparative half-year periods

Company release, 22 March 2023 at 12 p.m. (EET) Nightingale Health Plc ("Nightingale Health" or the "Company") published on 27 October 2022 its first consolidated financial statements prepared in accordance with IFRS for the financial year ended 30 June 2022. Before publishing the consolidated financial statements Nightingale Health provided comparative information on its consolidated statement of income, statement of financial position and key financials for the financial year ended 30 June 2021 and for the opening IFRS statement of financial position as at the transition date, 1 July

Deputy Governor Henry Ohlsson will leave the Riksbank at the end of June

Deputy Governor Henry Ohlsson has informed the Chair of the General Council Bo Broman that he will resign as Deputy Governor on 30 June 2023."I have been Deputy Governor of the Riksbank for more than eight years and they have in many ways been the best years in my professional life. I have been given the opportunity to apply the knowledge and experience I have with me from my time in the academic world to do what is best for Sweden. It has been a pleasure to make this journey together with all the knowledgeable employees at the Riksbank and my colleagues on the Executive Board. Nevertheless,

Breakthrough in plant-based production of Cyxone’s T20K

Cyxone (publ), a biotech company in autoimmune diseases, is developing T20K which acts to stop or slow down the progression of Multiple Sclerosis (MS). Researchers at the well renowned Center of Excellence for Innovations in Peptide and Protein Science, Australia have demonstrated a breakthrough in plant-based production of Cyxone’s T20K.The research findings means that sustainable, large scale and cost-effective production of cyclotide-based pharmaceuticals such as T20K, are now within reach.Since cyclotides are gene-encoded plant peptides, Professor David Craik and his team at University

UPM plans capacity reduction in Schongau and accelerates its exit plan in Steyrermühl

(UPM, Helsinki, 22 March 2023 at 11:35 EET) – UPM plans to adapt its uncoated publication paper capacity to a long-term profitable customer demand. The capacity reductions are planned to take place in Germany and Austria: · UPM Communication Papers plans to permanently close paper machine 6 at UPM Schongau, Germany, reducing the annual capacity of uncoated publication papers by 165,000 tonnes by the end of Q2 2023. · UPM Communication Papers accelerates the earlier announced stop of production at its Steyrermühl mill by six months. The exit of a total annual capacity of 320,000

BioStock: Targinta positions itself in the ADC field

The Antibody-Drug Conjugates area has grown rapidly in recent years with several research advances, market approvals, and licensing agreements. A clear example is Pfizer's 43 billion USD acquisition of Seagen announced on March 13. Swedish Targinta, with its unique cancer target and First-in-Class antibodies, has developed a strong position in the ADC field.Read the full article at biostock.se: https://www.biostock.se/en/2023/03/targinta-positions-itself-in-the-adc-field/ This is a press release from BioStock - Connecting Innovation & Capital. https://www.biostock.se

ArcticZymes Technologies announces CEO resignation

Tromsø, March 22nd 2023 – ArcticZymes Technologies ASA (OSE: AZT) announces that the Board of Directors has today accepted the voluntary resignation of Jethro Holter as Chief Executive Officer, due to personal reasons.The resignation will take effect on 30th September 2023 after the required 6 months notice period.  “On behalf of the Board, I want to thank Jethro very much for his outstanding contributions to ArcticZymes over the past 3 years that he has served as our CEO. During that time, Jethro has been instrumental in transforming ArcticZymes into a successful and highly profitable

Minesto participates in Sweden Innovation Days 2023 today

In conjunction with Sweden Innovation Days , Minesto CEO Dr Martin Edlund had the opportunity of being a part of the panel discussion hosted by Vinnova around the topic of “Raw materials supply for the green energy transition.”The free digital event is broadcasted online from CET 16.30 to 17.30. You can register here  to attend the event, you can also watch other presentations and panel discussions once you register. More information on the panel discussion Minesto is taking part in: https://

Invitation to presentation of Dustin's Interim report on March 29

Dustin Group will hold a conference call for investors, analysts and media on March 29 at CET 09:00 am with reference to the release of the Interim report for the second quarter 2022/23.CEO Thomas Ekman and CFO Johan Karlsson will present the financial result for the second quarter 2022/23 and answer questions. The conference call will be held in English. Related presentation material will be available at the corporate website www.dustingroup.com under Investors https://www.dustingroup.com/en/reports before the start of the conference call. Dustin Group will publish the Interim report

SEB’s The Green Bond report: the peak of CO2 emissions?

In the latest issue of SEB’s The Green Bond report, our experts explain how we have now reached the end of the beginning for the clean energy transition, or the point where the annual zero-emission energy growth outpaces the increase in total energy consumption and where absolute CO2 emissions start falling. As the United Nations gathers in New York for the first global conference about water in over fifty years, the report also explores the investment needs and opportunities to achieve the UN’s Sustainable Development Goal 6: clean water and sanitation. The energy shocks of the early

Speqta recruits Daniel Radu as CTO for Bidbrain

Speqta ("SPEQT") has recruited Daniel Radu as Chief Technology Officer for Bidbrain. Daniel has a solid background as tech lead for SaaS and e-commerce companies. Bidbrain, offering an advanced and transparent AI-based service for smarter bidding on Google Shopping ads, is now strengthening its team with a new Chief Technology Officer.Daniel Radu has a background from several companies in SaaS and e-commerce industries and has extensive experience in building both tech teams and scalable technical solutions. Daniel comes most recently from Apica, where he has been involved in

Annual General Meeting of Sandvik Aktiebolag

The shareholders in Sandvik Aktiebolag are convened to the Annual General Meeting to be held on Thursday, April 27, 2023 at 4:00 p.m. at the Göransson Arena, Sätragatan 21, Sandviken, Sweden. Registration will begin at 2:30 p.m. The award of the Wilhelm Haglund medal and the Sandvik Sustainability Award in Memory of Sigrid Göransson will take place at approx. 3:30 p.m. Coffee and tea will be served. RIGHT TO PARTICIPATE AND Notice There are two ways for shareholders to participate in the Meeting: (i) attending the Meeting in person or by proxy, or (ii) participating by postal

Vattenfall secures new credit facility

Vattenfall has secured a credit facility of EUR 3 billion, which is replacing bilateral facilities of EUR 4.3 billion that were established in 2022.The bilateral facilities were established for the purpose of securing Vattenfall’s liquidity during last year’s very volatile energy market. Since then, progress has been made in order to restructure the business for the purpose of reducing the inherent liquidity risks of Vattenfall’s business model. Together with a more stable energy market, this has led to a reduced need for liquidity. The new credit facility amounts to EUR 3 billion. -

BioStock: Abliva’s CEO about the phase II study

In December last year, Abliva initiated a potentially pivotal phase II study with KL1333. The candidate is being developed for the treatment of primary mitochondrial disease in adults, a group of rare diseases that lack effective treatment. CEO Ellen K. Donnelly visited BioStock’s studio to tell us more.See the full interview at biostock.se : https://www.biostock.se/en/2023/03/ablivas-ceo-about-the-phase-ii-study/ This is a press release from BioStock - Connecting Innovation & Capital. https://www.biostock.se

Aqilion to recieve 20.1 MSEK after conversion of outstanding warrants

In order to strengthen the company's liquidity and to ensure the continued development of the company's pipeline, on July 27, 2022 the Aqilion Board of Directors decided on to carry out an issue with priority for existing owners. The issue was carried out during the third quarter of 2022 as an issue of units, which brought the company approximately SEK 30.5 million before issue costs. Each unit contained four (4) shares and two (2) options of the subscription series TO1. All warrants (100%) in warrant series TO1 have now been converted to shares, which has added SEK 20.1 million to the

Metsä Board on the 2022 CDP Supplier Engagement Leaderboard

Metsä Board Corporation press release 22.03.2022Metsä Board, part of Metsä Group, has been recognised by CDP for their work to engage with suppliers to jointly tackle climate change. Only the top 8% of companies who disclosed information for the full climate questionnaire achieved a place on the CDP Supplier Engagement Leaderboard. The CDP Supplier Engagement assessment complements the CDP results published in December 2022, in which Metsä Board secured a place on CDP’s prestigious A List for tackling climate change, as well as using water resources and forests sustainably – all three

Metso Outotec’s Annual report for 2022 has been published

Metso Outotec Corporation’s stock exchange release on March 22, 2023, at 10:00 a.m. EETMetso Outotec has today, March 22, 2023, published its Annual report for 2022. The report consists of five sections that are Business overview, Financial review, Corporate governance statement, Remuneration report and GRI supplement.  Business overview comprises strategy, value creation and sustainability. Financial review consists of the Board of Directors' report, financial statements, Auditor’s report and investor information. Metso Outotec’s Board of directors’ report and financial statements is

BioStock: Xbrane's CEO on the launch of Ximluci in Europe

Together with its partner STADA, the biosimilar company Xbrane Biopharma is currently in the process of launching Ximluci, a biosimilar to the reference drug Lucentis for the treatment of a serious eye disease. In connection with the BioStock Investor Meeting, the company's CEO Martin Åmark talked about the product launch, the plans for the upcoming US launch and the licensing plans for the oncology portfolio.Watch the interview with Martin Åmark at biostock.se: https://www.biostock.se/en/2023/03/xbranes-ceo-on-the-launch-of-ximluci-in-europe/ This is a press release from BioStock -

Q4 Report - 31 December 2022

Flexion closes its strongest year to date with another record quarter. Total revenue grows by 108%, gross profit up 147% and adjusted EBITDA hits GBP 1.6mOctober-December 2022 performance · Total revenue increased by 108% to GBP 21.7m (10.5)* · Gross profit increased by 147% to GBP 3.7m (1.5) · Adjusted EBITDA[‡] increased to GBP 1.6m (0.4) · Adjusted profit before tax[#] increased to GBP 1.1m (0.6) · EPS amounted to GBP 2.78 pence (1.28 pence) · Adjusted EPS amounted to GBP 1.88 pence (1.32 pence) · Operating cash flow amounted to GBP 1.2m (0.5) · Cash and cash

Long-term incentive plan established for Raute's senior management and selected key persons

RAUTE CORPORATION STOCK EXCHANGE RELEASE MARCH 22, 2023 AT 9:45 A.M.   LONG-TERM INCENTIVE PLAN ESTABLISHED FOR RAUTE’S SENIOR MANAGEMENT AND SELECTED KEY PERSONS   Raute Corporation’s Board of Directors has decided on the commencement of a long-term incentive plan for the Group’s senior management and selected key persons. The decision includes a Performance Share Plan (“PSP”) as the main structure and a restricted Share Plan (“RSP”) as a complementary structure.   The purpose of the plan is to align the objectives of the owners and management in order to develop the

Annual Report 2022: Revenue growth of 45% and EBITDA growth of 20%

Company Announcement no. 02/202322 March 2023   The consolidated annual report for the period 1 January to 31 December 2022 was today approved by the Board of Directors. The full annual report is attached to this company announcement and can be found on our web site under www.wirtek.com/Investor-relations. CEO Michael Aaen comments: “We are pleased to report that despite a challenging macroeconomic environment during 2022, Wirtek still achieved great results with revenue growth of 45% and EBITDA growth of 20%. We expect double-digit organic revenue growth during 2023 in the

Swedish energy company selects Sectra’s service to protect critical systems against unauthorized access

Linköping – March 22, 2023 – International cybersecurity and medical imaging IT company Sectra  (STO: SECT B) has received an order for its Sectra Managed Detection and Response monitoring solution from Jönköping Energi. Proactive monitoring of critical systems will enable risks and vulnerabilities to be detected before they become a threat to day-to-day operations and thus to the region’s electricity supply.“We work every day to maintain a high level of delivery reliability in our electricity grid. We conduct maintenance and service on the grid to reduce the number of

Alfa Laval completes acquisition of innovative friction reduction technology

In 2021, Alfa Laval acquired a minority stake in the Netherland-based company Marine Performance Systems (MPS) with an option to acquire the remaining part later. Now Alfa Laval has executed that option and completed the acquisition to own 100 percent of MPS. The closing date for the acquisition was 21 March 2023. MPS’ innovative technology significantly reduces the friction from vessels when sailing, resulting in fuel savings.Friction between the hull and the water when sailing is the most significant driver of a vessel’s fuel consumption, and the cost of fuel represents up to 60 percent

Notice convening the Annual General Meeting of Nobia AB (publ)

The shareholders of Nobia AB (publ), reg. no. 556528-2752 (“Nobia” or the “Company”), are hereby given notice of the Annual General Meeting to be held on Thursday, April 27, 2023 at 13:00 CEST at S:ta Clara, Klarabergsviadukten 90, Stockholm.Right to participate in the Annual General Meeting: Shareholders who wish to participate in the Annual General Meeting must: firstly be included in the shareholders register maintained by Euroclear Sweden AB (“Euroclear”) as of Wednesday, 19 April, 2023; and,secondly notify Nobia of their participation at the Annual General Meeting

Publication of Biohit Oyj Renumeration Report 2022

Biohit Oyj Renumeration Report March 22, 2023 at 9:30 am local time (EET) Biohit Oyj’s Remuneration Report for the Governing Bodies is published today in PDF format. The Remuneration Report for the Governing Bodies is attached to this stock exchange release and also available at https://www.biohithealthcare.com/en/investors/. Additional information: CEO Jussi Hahtela, Biohit Oyjtel. +358 9 773 861investor.relations@biohit.fiwww.biohithealthcare.com  Biohit in brief Biohit Oyj is a globally operating Finnish biotechnology company.

There are no items matching the current filter
There are no more items matching the current filter
Back to top